documents: FDA-2014-N-1210-3467
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-N-1210-3467 | FDA | FDA-2014-N-1210 | Reference 37-Strober, M., et al., Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses | Supporting & Related Material | Background Material | 2019-03-05T05:00:00Z | 2019 | 3 | 2019-03-05T21:02:26Z | 0 | 0 | 0900006483875e81 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref